Global Somatostatin Receptor Type 2 Market Research Report 2024

Report ID: 1970090 | Published Date: Jan 2025 | No. of Page: 84 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Somatostatin Receptor Type 2 Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 CRN-00808
        1.2.3 Lanreotide Acetate
        1.2.4 PRL-2903
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Somatostatin Receptor Type 2 Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hormonal Disorder
        1.3.3 Oncology
        1.3.4 Metabolic Disorder
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Somatostatin Receptor Type 2 Market Perspective (2017-2028)
    2.2 Somatostatin Receptor Type 2 Growth Trends by Region
        2.2.1 Somatostatin Receptor Type 2 Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Somatostatin Receptor Type 2 Historic Market Size by Region (2017-2022)
        2.2.3 Somatostatin Receptor Type 2 Forecasted Market Size by Region (2023-2028)
    2.3 Somatostatin Receptor Type 2 Market Dynamics
        2.3.1 Somatostatin Receptor Type 2 Industry Trends
        2.3.2 Somatostatin Receptor Type 2 Market Drivers
        2.3.3 Somatostatin Receptor Type 2 Market Challenges
        2.3.4 Somatostatin Receptor Type 2 Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Somatostatin Receptor Type 2 Players by Revenue
        3.1.1 Global Top Somatostatin Receptor Type 2 Players by Revenue (2017-2022)
        3.1.2 Global Somatostatin Receptor Type 2 Revenue Market Share by Players (2017-2022)
    3.2 Global Somatostatin Receptor Type 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Somatostatin Receptor Type 2 Revenue
    3.4 Global Somatostatin Receptor Type 2 Market Concentration Ratio
        3.4.1 Global Somatostatin Receptor Type 2 Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Somatostatin Receptor Type 2 Revenue in 2021
    3.5 Somatostatin Receptor Type 2 Key Players Head office and Area Served
    3.6 Key Players Somatostatin Receptor Type 2 Product Solution and Service
    3.7 Date of Enter into Somatostatin Receptor Type 2 Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Somatostatin Receptor Type 2 Breakdown Data by Type
    4.1 Global Somatostatin Receptor Type 2 Historic Market Size by Type (2017-2022)
    4.2 Global Somatostatin Receptor Type 2 Forecasted Market Size by Type (2023-2028)
5 Somatostatin Receptor Type 2 Breakdown Data by Application
    5.1 Global Somatostatin Receptor Type 2 Historic Market Size by Application (2017-2022)
    5.2 Global Somatostatin Receptor Type 2 Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Somatostatin Receptor Type 2 Market Size (2017-2028)
    6.2 North America Somatostatin Receptor Type 2 Market Size by Country (2017-2022)
    6.3 North America Somatostatin Receptor Type 2 Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Somatostatin Receptor Type 2 Market Size (2017-2028)
    7.2 Europe Somatostatin Receptor Type 2 Market Size by Country (2017-2022)
    7.3 Europe Somatostatin Receptor Type 2 Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Somatostatin Receptor Type 2 Market Size (2017-2028)
    8.2 Asia-Pacific Somatostatin Receptor Type 2 Market Size by Country (2017-2022)
    8.3 Asia-Pacific Somatostatin Receptor Type 2 Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Somatostatin Receptor Type 2 Market Size (2017-2028)
    9.2 Latin America Somatostatin Receptor Type 2 Market Size by Country (2017-2022)
    9.3 Latin America Somatostatin Receptor Type 2 Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Somatostatin Receptor Type 2 Market Size (2017-2028)
    10.2 Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2017-2022)
    10.3 Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Amryt Pharma plc
        11.1.1 Amryt Pharma plc Company Detail
        11.1.2 Amryt Pharma plc Business Overview
        11.1.3 Amryt Pharma plc Somatostatin Receptor Type 2 Introduction
        11.1.4 Amryt Pharma plc Revenue in Somatostatin Receptor Type 2 Business (2017-2022)
        11.1.5 Amryt Pharma plc Recent Development
    11.2 Crinetics Pharmaceuticals Inc
        11.2.1 Crinetics Pharmaceuticals Inc Company Detail
        11.2.2 Crinetics Pharmaceuticals Inc Business Overview
        11.2.3 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Introduction
        11.2.4 Crinetics Pharmaceuticals Inc Revenue in Somatostatin Receptor Type 2 Business (2017-2022)
        11.2.5 Crinetics Pharmaceuticals Inc Recent Development
    11.3 Daewoong Pharmaceutical Co Ltd
        11.3.1 Daewoong Pharmaceutical Co Ltd Company Detail
        11.3.2 Daewoong Pharmaceutical Co Ltd Business Overview
        11.3.3 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Introduction
        11.3.4 Daewoong Pharmaceutical Co Ltd Revenue in Somatostatin Receptor Type 2 Business (2017-2022)
        11.3.5 Daewoong Pharmaceutical Co Ltd Recent Development
    11.4 Ipsen SA
        11.4.1 Ipsen SA Company Detail
        11.4.2 Ipsen SA Business Overview
        11.4.3 Ipsen SA Somatostatin Receptor Type 2 Introduction
        11.4.4 Ipsen SA Revenue in Somatostatin Receptor Type 2 Business (2017-2022)
        11.4.5 Ipsen SA Recent Development
    11.5 Progenics Pharmaceuticals Inc
        11.5.1 Progenics Pharmaceuticals Inc Company Detail
        11.5.2 Progenics Pharmaceuticals Inc Business Overview
        11.5.3 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Introduction
        11.5.4 Progenics Pharmaceuticals Inc Revenue in Somatostatin Receptor Type 2 Business (2017-2022)
        11.5.5 Progenics Pharmaceuticals Inc Recent Development
    11.6 Strongbridge Biopharma plc
        11.6.1 Strongbridge Biopharma plc Company Detail
        11.6.2 Strongbridge Biopharma plc Business Overview
        11.6.3 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Introduction
        11.6.4 Strongbridge Biopharma plc Revenue in Somatostatin Receptor Type 2 Business (2017-2022)
        11.6.5 Strongbridge Biopharma plc Recent Development
    11.7 Zucara Therapeutics Inc
        11.7.1 Zucara Therapeutics Inc Company Detail
        11.7.2 Zucara Therapeutics Inc Business Overview
        11.7.3 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Introduction
        11.7.4 Zucara Therapeutics Inc Revenue in Somatostatin Receptor Type 2 Business (2017-2022)
        11.7.5 Zucara Therapeutics Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Somatostatin Receptor Type 2 Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of CRN-00808
    Table 3. Key Players of Lanreotide Acetate
    Table 4. Key Players of PRL-2903
    Table 5. Key Players of Others
    Table 6. Global Somatostatin Receptor Type 2 Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Somatostatin Receptor Type 2 Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Somatostatin Receptor Type 2 Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Somatostatin Receptor Type 2 Market Share by Region (2017-2022)
    Table 10. Global Somatostatin Receptor Type 2 Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Somatostatin Receptor Type 2 Market Share by Region (2023-2028)
    Table 12. Somatostatin Receptor Type 2 Market Trends
    Table 13. Somatostatin Receptor Type 2 Market Drivers
    Table 14. Somatostatin Receptor Type 2 Market Challenges
    Table 15. Somatostatin Receptor Type 2 Market Restraints
    Table 16. Global Somatostatin Receptor Type 2 Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Somatostatin Receptor Type 2 Market Share by Players (2017-2022)
    Table 18. Global Top Somatostatin Receptor Type 2 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Somatostatin Receptor Type 2 as of 2021)
    Table 19. Ranking of Global Top Somatostatin Receptor Type 2 Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Somatostatin Receptor Type 2 Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Somatostatin Receptor Type 2 Product Solution and Service
    Table 23. Date of Enter into Somatostatin Receptor Type 2 Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Somatostatin Receptor Type 2 Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Somatostatin Receptor Type 2 Revenue Market Share by Type (2017-2022)
    Table 27. Global Somatostatin Receptor Type 2 Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Somatostatin Receptor Type 2 Revenue Market Share by Type (2023-2028)
    Table 29. Global Somatostatin Receptor Type 2 Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Somatostatin Receptor Type 2 Revenue Market Share by Application (2017-2022)
    Table 31. Global Somatostatin Receptor Type 2 Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Somatostatin Receptor Type 2 Revenue Market Share by Application (2023-2028)
    Table 33. North America Somatostatin Receptor Type 2 Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Somatostatin Receptor Type 2 Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Somatostatin Receptor Type 2 Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Somatostatin Receptor Type 2 Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Somatostatin Receptor Type 2 Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Somatostatin Receptor Type 2 Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Somatostatin Receptor Type 2 Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Somatostatin Receptor Type 2 Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Amryt Pharma plc Company Detail
    Table 44. Amryt Pharma plc Business Overview
    Table 45. Amryt Pharma plc Somatostatin Receptor Type 2 Product
    Table 46. Amryt Pharma plc Revenue in Somatostatin Receptor Type 2 Business (2017-2022) & (US$ Million)
    Table 47. Amryt Pharma plc Recent Development
    Table 48. Crinetics Pharmaceuticals Inc Company Detail
    Table 49. Crinetics Pharmaceuticals Inc Business Overview
    Table 50. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product
    Table 51. Crinetics Pharmaceuticals Inc Revenue in Somatostatin Receptor Type 2 Business (2017-2022) & (US$ Million)
    Table 52. Crinetics Pharmaceuticals Inc Recent Development
    Table 53. Daewoong Pharmaceutical Co Ltd Company Detail
    Table 54. Daewoong Pharmaceutical Co Ltd Business Overview
    Table 55. Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Product
    Table 56. Daewoong Pharmaceutical Co Ltd Revenue in Somatostatin Receptor Type 2 Business (2017-2022) & (US$ Million)
    Table 57. Daewoong Pharmaceutical Co Ltd Recent Development
    Table 58. Ipsen SA Company Detail
    Table 59. Ipsen SA Business Overview
    Table 60. Ipsen SA Somatostatin Receptor Type 2 Product
    Table 61. Ipsen SA Revenue in Somatostatin Receptor Type 2 Business (2017-2022) & (US$ Million)
    Table 62. Ipsen SA Recent Development
    Table 63. Progenics Pharmaceuticals Inc Company Detail
    Table 64. Progenics Pharmaceuticals Inc Business Overview
    Table 65. Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product
    Table 66. Progenics Pharmaceuticals Inc Revenue in Somatostatin Receptor Type 2 Business (2017-2022) & (US$ Million)
    Table 67. Progenics Pharmaceuticals Inc Recent Development
    Table 68. Strongbridge Biopharma plc Company Detail
    Table 69. Strongbridge Biopharma plc Business Overview
    Table 70. Strongbridge Biopharma plc Somatostatin Receptor Type 2 Product
    Table 71. Strongbridge Biopharma plc Revenue in Somatostatin Receptor Type 2 Business (2017-2022) & (US$ Million)
    Table 72. Strongbridge Biopharma plc Recent Development
    Table 73. Zucara Therapeutics Inc Company Detail
    Table 74. Zucara Therapeutics Inc Business Overview
    Table 75. Zucara Therapeutics Inc Somatostatin Receptor Type 2 Product
    Table 76. Zucara Therapeutics Inc Revenue in Somatostatin Receptor Type 2 Business (2017-2022) & (US$ Million)
    Table 77. Zucara Therapeutics Inc Recent Development
    Table 78. Research Programs/Design for This Report
    Table 79. Key Data Information from Secondary Sources
    Table 80. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Somatostatin Receptor Type 2 Market Share by Type: 2021 VS 2028
    Figure 2. CRN-00808 Features
    Figure 3. Lanreotide Acetate Features
    Figure 4. PRL-2903 Features
    Figure 5. Others Features
    Figure 6. Global Somatostatin Receptor Type 2 Market Share by Application in 2021 & 2028
    Figure 7. Hormonal Disorder Case Studies
    Figure 8. Oncology Case Studies
    Figure 9. Metabolic Disorder Case Studies
    Figure 10. Others Case Studies
    Figure 11. Somatostatin Receptor Type 2 Report Years Considered
    Figure 12. Global Somatostatin Receptor Type 2 Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Somatostatin Receptor Type 2 Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Somatostatin Receptor Type 2 Market Share by Region: 2021 VS 2028
    Figure 15. Global Somatostatin Receptor Type 2 Market Share by Players in 2021
    Figure 16. Global Top Somatostatin Receptor Type 2 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Somatostatin Receptor Type 2 as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Somatostatin Receptor Type 2 Revenue in 2021
    Figure 18. North America Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Somatostatin Receptor Type 2 Market Share by Country (2017-2028)
    Figure 20. United States Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Somatostatin Receptor Type 2 Market Share by Country (2017-2028)
    Figure 24. Germany Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Somatostatin Receptor Type 2 Market Share by Region (2017-2028)
    Figure 32. China Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Somatostatin Receptor Type 2 Market Share by Country (2017-2028)
    Figure 40. Mexico Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Somatostatin Receptor Type 2 Market Share by Country (2017-2028)
    Figure 44. Turkey Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Amryt Pharma plc Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2017-2022)
    Figure 47. Crinetics Pharmaceuticals Inc Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2017-2022)
    Figure 48. Daewoong Pharmaceutical Co Ltd Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2017-2022)
    Figure 49. Ipsen SA Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2017-2022)
    Figure 50. Progenics Pharmaceuticals Inc Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2017-2022)
    Figure 51. Strongbridge Biopharma plc Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2017-2022)
    Figure 52. Zucara Therapeutics Inc Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amryt Pharma plc
Crinetics Pharmaceuticals Inc
Daewoong Pharmaceutical Co Ltd
Ipsen SA
Progenics Pharmaceuticals Inc
Strongbridge Biopharma plc
Zucara Therapeutics Inc
Frequently Asked Questions
Somatostatin Receptor Type 2 report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Somatostatin Receptor Type 2 report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Somatostatin Receptor Type 2 report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports